Alert detail

LCD L37919: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test — WPS

Policy ID: LCD-L37919Specialty: PulmonologyAdded: 9/13/2026Effective: June 29, 2023lcd
Low

What changed

WPS covers Envisia™ IPF genomic classifier under MolDX framework.

Who’s affected: Pulmonology billing teams · Effective: June 29, 2023

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 7 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.